poisar

Stocks · News reference

Theralase Technologies Inc. Provides Bladder Cancer Clinical Study Update

Fiscal.ai

Theralase Technologies Inc. announced the completion of enrollment for its Phase II clinical study of its bladder cancer treatment and outlined plans for future regulatory submissions.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading